References
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–235
- Segre E. J. Naproxen metabolism in Man. J Clin Pharmacol 1975; 15: 316–323
- Kauffmann R. E., Bolliger R. O., Wan S. H., Oren J. Pharmacokinetics and metabolism of Naproxen in children. Dev Pharmacol Ther 1982; 5: 143–150
- Fredell E. W., Strand L. J. Naproxen overdose. JAMA 1977; 238: 938
- Wilkinson A. R., Aynsley-Green A., Mitchell M. D. Persistent pulmonary hypertension and abnormal prostaglandin E levels after maternal treatment with naproxen. Arch Dis Childh 1979; 54: 942–945
- Wilkinson A. R. Naproxen levels in pre-term infants after maternal treatment. Lancet 1980; 2: 591–592
- Halliday H. L., Hirata T., Brady J. P. Indomethacin therapy for large patient ductus arteriosus in the very low birth weight infant: results and complications. Pediatrics 1979; 64: 154–159
- Feldman D., Loose D. S., Tan S. Y. Nonsteroidal anti-inflammatory drugs cause sodium and water retention in the rat. Am J Physiol 1978; 234: 490–496
- Personal Communication. Syntex Pharmaceuticals Ltd.
- Temple A. R., George D. J., Done A. K., Thompson J. A. Salicylate poisoning complicated by fluid retention. Clin Tox 1976; 9: 61–68